Overview
The Health Systems Innovation Lab is engaging Changing Diabetes in Children, a public private partnership between Novo Nordisk and 14 collaborating countries in Africa and Asia, to expand the provision of high-value health services for T1D to children and adolescents. A highly collaborative program consisting of leading clinicians, scientists, and researchers, the GC-CDIC conducts activities in four major streams: I) Digital data systems; II) Research; III) Innovation Lab; IV) Translation Hub.
Seminal Studies
Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis
Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: A scoping review
Incidence and prevalence of type 1 diabetes and diabetic ketoacidosis in children and adolescents (0-19 years) in Thailand (2015-2020): A nationwide population-based study
The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review